Recombinant Anti-CD33 x Anti-DENV VHH BispecificAntibody (IgG-VHH) (IGVHH-035)

Recombinant Anti-CD33 x Anti-DENV Bispecific Antibody (IgG-VHH) is designed to be expressed as a LC and an extended HC with VHH moiety linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, bivalent for each antigen specificity, 2+2 antigen-binding valency. This BsAb is designed for the research of antibody-dependent enhancement (ADE) and dengue virus infection.

Datasheet INQUIRY

Specifications

Targets

CD33 & DENV

Type

Appended IgGs

Species Reactivity

Human

Application

FuncS

Related Disease

Dengue virus infection

Targets

Target 1

CD33

Gene ID

945

UniProt ID

P20138

Alternative Names

CD33; CD33 molecule; Cluster of differentiation 33; p67; SIGLEC3; SIGLEC-3; myeloid cell surface antigen CD33; gp67; CD33 antigen (gp67); sialic acid binding Ig-like lectin 3; sialic acid-binding Ig-like lectin 3

Target 2

DENV

Alternative Names

dengue virus; DENV; dengue fever; Flavivirus

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD33 x Anti-DENV VHH BispecificAntibody (IgG-VHH) (IGVHH-035). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CD33 x Anti-DENV VHH BispecificAntibody (IgG-VHH) (CAT#: IGVHH-035)

Specifications

Targets

Customer Reviews and Q&As